INTRODUCTION
Sepsis has long been recognized to be associated with nervous system dysfunction (Levy et al., 2003; Baron et al., 2006) . Indeed, altered mental status is present in about a quarter of sepsis patients (Sprung et al., 1990) and can even occur before other signs (Ebersoldt et al., 2007) . Moreover, sepsis-associated encephalopathy, for diffuse or multifocal cerebral dysfunction, ranging from lethargy to coma, is present in 70% of patients with bacteremia (Wilson and Young, 2003) . Finally, severe sepsis survivors often develop long-term cognitive impairments and behavioral problems and experience a reduction in quality of life comparable to that seen after a heart attack (Heyland et al., 2000; Iwashyna et al., 2010; Lazosky et al., 2010; Pandharipande et al., 2013) .
Given that the brain is highly dependent on blood supply to function properly (Rolfe and Brown, 1997) and that sepsis comes with a high risk of organ hypoperfusion (Jones and Puskarich, 2009) , it is likely that sepsisassociated encephalopathy is related to reduced cerebral blood flow. Septic patients with encephalopathy do indeed show a reduction in global cerebral blood flow compared to healthy controls (Bowton et al., 1989; Maekawa et al., 1991) . Interestingly, this finding can be reproduced by intravenous administration of bacterial lipopolysaccharides (LPS) in human volunteers (Moller et al., 2002) . However, the techniques used in these initial studies did not allow for determination where the reduction in flow occurred in the cerebral blood supply. More recent clinical studies have applied time-of-flight (TOF) magnetic resonance angiography (MRA) to sepsis-associated encephalopathy and shown anatomical signs of vasospasms in branches of the anterior and middle cerebral arteries (ACA and MCA) (Bartynski et al., 2006; Polito et al., 2013) . In addition, flow speed in the territory of the MCA, as measured with transcranial Doppler, has been shown to be reduced after iv LPS administration in healthy volunteers (Brassard et al., 2012) . These findings indicate that vasoconstrictive mechanisms in brainsupplying arteries may reduce cerebral blood flow during sepsis.
In the present work, we set out to better understand sepsis-associated changes in cerebral arterial bloodsupply by trying to model these in animals. Timeresolved 3D TOF MRA was used to functionally characterize the high-flow systems of the circle of Willis, ACA and MCA during systemic inflammation after intravenous administration of bacterial LPS in mice. In animals, prostaglandins, nitric oxide and endothelin-1 (ET-1) have been shown to be vasoactive molecules in brain arteries and arterioles (Toda et al., 1988; Faraci and Brian, 1994; Salom et al., 1995; Davidge, 2001; Jadhav et al., 2004; Dabertrand et al., 2013) . Interestingly, in vitro rodent cerebral arteries rapidly respond to LPS by increasing the expression of cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin synthesis (Hernanz et al., 2004) . Moreover, systemic administration of bacterial LPS or pro-inflammatory cytokines increases cerebral expression of the prostaglandinsynthesizing enzymes COX-2 and microsomal prostaglandin E synthase (mPGES) as well as that of inducible nitric oxide synthase (iNOS) and ET-1 in rodents (Wong et al., 1996; Elmquist et al., 1997; Konsman et al., 1999 Konsman et al., , 2004 Ek et al., 2001; Yamagata et al., 2001; Shimojo et al., 2006; Eskilsson et al., 2014) . Since increased expression of these molecules involves nuclear factor-kappaB (NF-jB) (D'Acquisto et al., 1997; Abate et al., 1998; Zhao et al., 2001; Wort et al., 2009) , we set out to study expression of this transcription factor in addition to that of the more general cellular activation marker c-Fos, COX-2, mPGES, iNOS and ET-1 in the brains of animals that underwent MRA as a first approach to determine potential mechanisms underlying sepsis-related changes in cerebral blood flow.
EXPERIMENTAL PROCEDURES Animals
Experiments were conducted according to European recommendations on animal research (European Council Directive of 24 November 1986 (86/609/EEC) and European Parliament and Council Directive of 22 September 2010 (2010/63/UE)) and approved by the local committee for animal experimentation (AS-SNC-DEV Dir1434). After arrival, 20 male 3-month-old C57/ Bl6 (Charles River, Arbresle, France) were allowed at least one week of acclimation in group cages with ad libitum access to food and water in a temperature (22°C ± 1°C)-controlled environment where lights were on from 08:00 to 20:00 h.
Magnetic resonance imaging
On the day of experiment, mice were removed from their cage, anesthetized with 1.5-2.0% isoflurane and an intravenous catheter placed into their caudal tail vein. This catheter was connected to a syringe containing either LPS or saline. Under continued anesthesia, mice were then placed in a 4.7 T horizontal magnet (Bruker, Ettlingen, Germany) equipped with a 6-cm BG6 gradient system capable of generating 950 mT/m maximum strength and an 80-ls rise time. During imaging, respiratory rate was monitored and maintained between 80 and 100 breaths per minute and body temperature sustained by warm water circulating in the machine's gradients.
Time-resolved 3D MRA
Blood flow in internal carotids, the circle of Willis and the first segments of the ACA and MCA was assessed using a slightly modified bright blood time-resolved 3D MRA sequence previously developed and validated for the mouse carotid system (Miraux et al., 2006) . It covered filling of the circle of Willis and the ACA and MCA by arterial blood in 8 images spanning 64 ms with a field of view of 2.0 Â 1.6 Â 1.4 cm and a matrix of 128 Â 80 Â 48 voxels, thus yielding a spatial resolution of 156 Â 200 Â 292 lm. The sequence was applied once before intravenous injection and repeated 6 times over time thereafter. Subtraction operations between the images covering 64 ms were performed in IGOR Pro 6.04 (Wavemetrics, Lake Oswego, OR, USA) to yield the number of voxels that have appeared in a given interval as a measure of the blood volume that has filled different arterial segments over time. After application of a fixed intensity threshold, the values obtained in the subtracted images after intravenous injection were divided by those measured in equivalent subtracted and thresholded images of the same animal before treatment (baseline). Thus, timeresolved 3D MRA assesses flow during a ''time interval of interest" rather than in a ''region of interest", even though one can determine a posteriori which arterial segments were filled during the interval in question.
3D MRA
In addition to time-resolved 3D MRA to assess flow in the circle of Willis as well as in the ACA and MCA, a 3D MRA sequence on coronal slices with a field of view of 2.0 Â 1.6 Â 1.4 cm and a matrix of 128 Â 96 Â 64 voxels, thus yielding a spatial resolution of 156 Â 167 Â 219 lm, was used to estimate flow in the internal carotids, ACA and MCA as well as in some of its major branches. This MRA sequence was alternated with time-resolved 3D MRA, applied once before intravenous injection and repeated 7 times over time thereafter. The coronal orientation was chosen to maximize the axial ''entrance effect" of fresh blood as the direction of flow in the arteries of interest is often horizontal. The bright appearance of blood allowed for identification of a fixed internal reference position slice. Regions of interests (ROIs) centered on the internal carotid arteries, ACA, MCA, pericallosal azygos artery and anterior amygdaloid arteries were then placed on more anterior or posterior slices relative to the reference slice. Sizes of these ROIs varied from 4 voxels for the smallest artery, the pericallosal azygos artery, to 9-10 voxels for the largest arteries, the internal carotids. The mean intensity of voxels in each artery was measured in Image J (http://rsbweb.nih.gov/ij/) and expressed relative to the mean intensity to a ROI of the same form and surface placed in a corner of the same image but outside the head (background). The resulting blood flow proxies after intravenous injection were expressed relative to that in the same ROIs of the same animal before treatment (baseline). Thus, this 3D MRA sequence allows for a ''region of interest" approach, but at the expense of being able to compare different ''time intervals of interest" to assess blood flow, even though the intensity of gray levels contains this information to some extent. As such it is comparable to the MRA sequences routinely used in the clinic and complementary to the time-resolved 3D MRA described above and with which it was alternated.
Treatment
Once baseline MRAs were completed, 37.5 lg (1.25 mg/ kg) of Escherichia coli LPS (Serotype 0127:B8, Sigma, St Louis, MO, USA) dissolved in 150 ll of 0.9% NaCl or an equivalent volume of 0.9% NaCl vehicle was injected intravenously (iv) over one minute. This dose of LPS is more than ten times lower than the one needed to induce 50% mortality within 72 h when given by the same route (Eskandari et al., 1992) . Indeed, 50 lg of the same serotype of LPS injected intravenously does not result in any mortality until 40 h after injection, but does induce increases in circulating concentrations of pro-inflammatory cytokines and apoptosis in gut epithelium (Blank et al., 1997) .
Tissue preparation
Two and a half hours after injection, and upon completion of the last MRA sequence, animals were removed from the magnet and injected with sodium pentobarbital (0.3 ml of 550 mg/ml) while still under isoflurane anesthesia. Once the hind paw reflex upon plantar pinching had disappeared, the thoracic cage was opened to allow for placement of a needle into the left cardiac ventricle after the right atrium was cut. The circulatory system of animals was next rinsed with phosphate-buffered saline (PBS) after which brains of that half of the animals allocated to polymerase chain reaction (PCR) experiments were removed within two minutes, frozen on crushed dry ice and stocked at À80°C while the remaining mice assigned to immunohistochemical analyses were perfused with 4% paraformaldehyde in 0.1 M PBS. After removal of these perfusion-fixed brains, they were post-fixed for 4 h, cryoprotected in 30% sucrose, frozen on dry ice and stocked at À80°C.
Real-time PCR
After RNA was extracted and reverse transcribed to cDNA, real-time SYBR green-based comparative PCR was performed using a previously established protocol and set of primers (Pourtau et al., 2014) . Expression of mRNA coding for COX2, mPGES, iNOS and preproET-1 relative to that of beta-actin was calculated as 2 ÀDC T (Schmittgen and Livak, 2008) and as fold change (Pfaffl et al., 2002) . Relative expressions of monocyte chemoattractant protein-1 (MCP-1)/CCL2 and tumor necrosis factor-a (TNFa) were used as positive controls.
Immunohistochemistry
Brains were cut on a cryostat into 30-lm-thick sections that were collected in cold cryoprotectant (0.05 M phosphate buffer, 20% glycerol and 30% ethylene glycol) and stored at À20°C until further processing. After washing off the cryoprotectant solution, immunohistochemical processing was performed on a one in six series of free-floating sections using the strepta vidin-biotin-immunoperoxidase technique (Konsman and Blomqvist, 2005) . Briefly, non-specific binding sites were blocked by a 1-h incubation of sections in PBS, pH 7.4, containing 0.3% Triton X-100 and 1.0% bovine albumin. A rabbit antiserum recognizing the transcription factor c-Fos (Sc-52, Santa Cruz Biotechnology, Heidelberg, Germany; diluted 1:2000), amply characterized in the past including by us (Konsman and Blomqvist, 2005; Konsman et al., 2008) , was used to study neuronal activation. A goat antiserum directed against the p65 subunit of NF-jB (Sc-372, Santa Cruz Biotechnology, Heidelberg, Germany; diluted 1:500), characterized previously (Nadjar et al., 2003) was employed to assess proinflammatory signaling. A goat antiserum recognizing COX-2 (Sc-1747, Santa Cruz Biotechnology, Heidelberg, Germany; diluted 1:500), employed by our team in the past (Konsman et al., 2004) was utilized to identify cerebral sites of prostaglandin synthesis. Moreover, the c-Fos, COX-2 and NF-kappa-B antisera used in the present work are part of the Journal of Comparative Neurology antibody database that contains collected information on the antibodies used for immunohistochemistry based on that journal's policy requiring rigorous characterization for antibodies. A rabbit antiserum specific for nitrosylated tyrosine residues (nitrotyrosine; Millipore, Fontenay sous Bois, France, diluted 1:250) was used as readout for the production of NO and peroxynitrite during inflammation. Antisera were added at dilutions indicated to PBS, 0.3% Triton X-100 and 1.0% bovine albumin. Sections were incubated in antiserum-containing buffers overnight at room temperature. After four rinses in PBS, sections were treated for 30 min in 0.3% (v/v) hydrogen peroxide to block endogenous peroxidases followed by rinses in PBS. Sections were incubated for 2 h at room temperature with either biotinylated donkey anti-rabbit IgG (Amersham, Les Ulis, France) or biotinylated rabbit anti-goat IgG (Dako, Les Ulis, France) diluted 1:500 in PBS containing 0.3% Triton X-100 and 1.0% bovine albumin and stained using the ABC protocol (Vectastain Elite, Vector Laboratories, Eurobio/Abcys, Les Ullis, France) with nickel-enhanced diaminobenzidine as a chromagen.
Stained sections were observed on a microscope (Leica DM5500B, Leica Microsystems, Wetzlar, Germany) under bright field illumination and images were captured by a high-resolution CCD video camera image and stored on a personal computer. Image editing software (Adobe Photoshop, Adobe Systems, San Jose, CA, USA) was used to adjust contrast and brightness only and to prepare microphotographs. Sections were also examined under ultraviolet (UV) light to distinguish between arteries and other vessel types. Indeed, excitation in the UV range provokes an autofluorescence of elastin in the wall of arteries, whereas veins are less autofluorescent due to a reduced amount of elastin (Kingsley et al., 2001; Hernanz et al., 2004) .
Data presentation and analysis
MRA data were expressed as means ± standard error of the mean (SEM) of change relative to baseline over time after injection. These data were analyzed both as area under the curve (AUC) by Student-t tests with iv treatment as a between factor and by analyses of variance (ANOVA) with iv treatment as a between factor and post-injection time as a within factor. Significant effects and interactions were further analyzed by the Newman-Keuls post hoc test. The number of c-Fosimmunoreactive cells was determined in at least two sections of the ventromedial preoptic area, supraoptic and paraventricular nuclei of the hypothalamus in each animal and analyzed by a Mann-Whiney U test. Realtime PCR data were expressed as 2 ÀDC T and analyzed by a one-way ANOVA (Schmittgen and Livak, 2008) . In case a significant difference was found, data were expressed as fold change and analyzed using Pair-Wise Fixed Reallocation Randomization Tests, which take into account real amplification efficiencies (Pfaffl et al., 2002) . In all cases, a level of p < 0.05 was considered as statistically significant.
RESULTS

Iv LPS resulted in lower cerebral blood flow in the circle of Willis and in the anterior cerebral arteries
3D time-resolved MRA. An example of time-resolved 3D MRA represented by sequential maximum intensity projections and indicating the different time intervals (I1-7) is shown in Fig. 1A . The time-resolved 3D MRA sequence used here previously has been used to determine blood flow velocity in the mouse carotids to be $25 cm/s (Miraux et al., 2006) . For comparative purposes, the fronts of bright blood voxels were determined at 8, 16 and 24 ms on the maximum intensity projection flatmaps, as these correspond to filling of the internal carotids during I1 and I2, which occurred in an almost straight line in an approximately horizontal plane, to estimate flow. As 19 voxels had appeared during the progression of the anterior front of filling of the internal carotids between 8 and 24 ms along the z-axis, corresponding to 19 Â 0.219 mm (voxel size of 219 lm in z taking into consideration voxel spatial resolution and the field of view) = 4.2 mm, this calculation yielded an estimate of 26.25 cm/s flow velocity for the internal carotids, which is compatible with the values determined for the mouse carotids in our previous work (Miraux et al., 2006) .
The Student-t tests on AUC of data expressed as changes relative to baseline showed no differences in arterial flow between treatments during I1 and I2, which corresponded to filling of the internal carotids and basilar artery. However, the same analyses revealed tendencies for lower flow during I3 corresponding to filling of the circle of Willis formed by the continuation of the internal carotids and the posterior communicating artery (t 1,14 = 1.98, p = 0.067) as well as during I4 all through which the anterior and middle cerebral arteries were filled (t 1,14 = 1.92, p = 0.074) in mice that were given LPS as compared to those that received its vehicle.
Since blood flow may increase with time of isoflurane anesthesia (Sicard et al., 2003; Duong, 2007; Shin et al., 2007) , the relative number of voxels that appeared between sequential images of the filling of the circle of Willis were also analyzed by repeated-measures ANO-VAs. These analyses indicated indeed significantly increased flow over time after iv injection (F 5,65 = 2.52: p < 0.05), but no effect of treatment during I1 (Fig. 1A) , that is during filling of the internal carotids upstream of the circle of Willis and that of the basilar artery. With respect to I3 (Fig. 1A) corresponding to filling of the lateral parts of the circle of Willis, flow also increased significantly with time of the experiment (F 5,60 = 4.05: p < 0.01). However, iv LPS treatment tended to result in lower flow in these vessels as compared to iv administration of saline (F 1,12 = 4.34, p = 0.059; Fig. 1B ). Since a significant interaction occurred between time and treatment for filling of these segments (F 5,60 = 2.43: p < 0.05), post hoc tests were performed. These indicated that flow was significantly lower 80 min after iv LPS injection as compared to administration of its vehicle (LPS < Sal; p < 0.05; Fig. 1B ). Analysis of flow during I4 (Fig. 1A) , which corresponded to filling of the initial segments of the anterior and middle cerebral arteries (ACA and MCA), showed that, in addition to the increase over time (F 5,65 = 4.02: p < 0.01), flow was lower in mice that received iv LPS than in animals that were given saline iv (F 1,13 = 8.06, p < 0.05; Fig. 1C ).
3D MRA. Given that iv LPS compared to iv saline administration resulted in lower flow during the interval corresponding to the filling of the first segments of the ACA and MCA, blood flow in ROIs placed on these arteries as well as on some of their up-and downstream arteries were assessed using 3D MRA in coronallyoriented virtual brain slices ( Fig. 2A) . The Student-t tests on AUC of data expressed as changes relative to baseline showed lower flow in the right ACA (t 1,15 = 2.47, p < 0.05) and the azygos pericallosal artery (t 1,15 = 3.12, p < 0.01) as well as a tendency for lower flow in the left ACA (t 1,15 = 1.96, p = 0.069) in mice that were injected with LPS as compared to those that were administered saline.
Since blood flow may increase with time of isoflurane anesthesia (Sicard et al., 2003; Duong, 2007; Shin et al., 2007) , flow data obtained in ROIs placed on arteries were also analyzed by repeated-measures ANOVAs. ANOVAs with treatment as a between factor and time after injection as a within subject factor indicated that blood flow was lower in ROIs placed on the ACAs at the base of the brain after iv LPS injection than after iv saline administration (F 1,15 = 6.08, p < 0.05 and F 1,15 = 4.91, p < 0.05 for the right and left ACA, respectively; Fig. 2C ), whereas flow in the internal carotids upstream of the circle of Willis ( Fig. 2B ) and in the MCAs was not different between treatments, but did increase over time (F 6,90 = 3.20, p < 0.01 and F 6,90 = 3.27, p < 0.01 for right and left carotid, respectively). When similar analyses were employed on brain-irrigating arteries downstream of the ACA, iv LPS injection was found to result in significantly lower blood flow compared to iv saline administration in the azygos pericallosal artery (F 1,15 = 9.75, p < 0.01; Fig. 2E ) while flow globally significantly increased over time (F 6,90 = 3.20, p < 0.01). The anterior amygdaloid arteries showed a tendency (F 6,90 = 2.08, p = 0.063) and a significant interaction (F 6,90 = 2.36, p < 0.05) between iv treatment and time after injection for this vessel in the right and left hemisphere, respectively. Post-hoc tests did however not indicate any differences between iv LPS and saline treatments at the different time points after injection in this artery (Fig. 2D) .
Iv LPS increased cerebral expression of prostaglandin H 2and E 2 -synthesizing enzymes
The assumptions for application of the comparative C T method are that amplification efficiencies of cDNAs of genes of interest and that of cDNA of the control gene are similar and close to 1. In the present conditions the efficiency of cDNA amplification of the control actin was 0.9 and that of genes of interest 0.98-1.06, a difference that may affect fold changes of expression. The expression of genes for which a oneway ANOVA on 2 ÀDC T data, the calculation of which presupposes amplification efficiencies close to 1 (Schmittgen and Livak, 2008) , indicated a significant difference were therefore further analyzed using the Relative Expression Software Tool (REST) for group-wise comparison and statistical analysis of relative expression that takes into account real amplification efficiencies (Pfaffl et al., 2002) . Isoflurane anesthesia, like other anesthetics, has been shown to exert anti-inflammatory effects and to attenuate LPS-induced TNFa expression in peripheral tissues (de Rossi et al., 2004; Flondor et al., 2008) . Induction of classical inflammatory molecules in the brain was therefore studied before addressing the effect of iv LPS on the cerebral expression of vasoactive mediators. TNFa and MCP-1/CCL2 mRNAs in the brain increase after peripheral administration of LPS in mice (Laye´et al., 1994; Reyes et al., 2003) and were therefore used as positive controls in the present study. Analyses of 2 ÀDC T and fold changes of MCP-1/CCL2 and TNFa mRNAs indicated significant increases 2.5 h after iv LPS treatment with expressions being 4.0 and 12.4 times higher, respectively, as compared to administration of its vehicle (Table 1) . The iv LPS-induced increase in TNFa mRNA under isoflurane anesthesia found in the present study was larger than that reported at a comparable time point after iv administration of a similar dose of LPS, but under ketamine-medetomodine anesthesia (Ruiz-Valdepenas et al., 2011) . Thus, even though isoflurane may exert anti-inflammatory effects, it seems less important than for some other types of anesthesia and still allows for the study of cerebral expression of inflammatory mediators. A one-way ANOVA on 2 ÀDC T COX-2 mRNA data indicated significantly higher expression after iv LPS administration than after iv saline injection. REST analysis confirmed this effect and allowed to determine that COX-2 mRNA expression was 2.4 times higher in LPS-treated mice than in animals that received saline (Table 1) . A oneway ANOVA on 2 ÀDC T mPGES mRNA data indicated significantly higher expression 2.5 h after iv LPS administration as compared to iv saline injection (Table 1) . However, when taking into account real amplification efficiencies in the REST analysis this effect was reduced to one at the limit of significancy with a 1.4 times higher mPGES mRNA expression in LPS-treated mice than in animals that were given saline ( Table 1) . Analyses of 2 ÀDC T and fold change of preproET-1 and iNOS mRNAs data did not reveal any significant differences between LPS and saline treatment 2.5 h after their iv administration (Table 1) .
Iv LPS-induced inflammatory signaling and prostaglandin synthesis did not occur in cerebral arteries c-Fos. The lower flow in the ACA and in the internal carotids within the circle of Willis of mice injected with LPS as compared to those administered saline may therefore be related to differences in neuronal activity in the cerebral territories supplied by these arteries. As the preoptic region and the supraoptic and paraventricular nuclei of the hypothalamus receive their blood supply largely from the ACA and internal carotids (Ambach and Palkovits, 1974a,b; Ambach et al., 1978) , the neuronal activation marker c-Fos was detected in these structures by immunohistochemistry and compared between iv saline-and iv LPS-injected animals. Although no differences in the number of c-Fosimmunoreactive cells were observed between treatments in the ventromedial preoptic area (saline: 15.5 ± 8.2; LPS 20.4 ± 7.1; U = 4.0, n sal = 3, n LPS = 4, p > 0.10) and the supraoptic nucleus (saline: 8.3 ± 2.4; LPS 11.9 ± 3.2; U = 6.0, n sal = 4, n LPS = 4, p > 0.10), LPS treatment was found to decrease the number of c-Fos-positive cells in the paraventricular nucleus of the hypothalamus (saline: 73.3 ± 3.4; LPS 41.3 ± 4.7; U = 0.0, n sal = 3, n LPS = 3, p < 0.05).
NK-jB.
In contrast to c-Fos induction, the expression of which can be provoked by a wide variety of stimuli, the nuclear translocation of NF-jB occurs more specifically in response to inflammatory stimuli, including LPS and proinflammatory cytokines (D'Acquisto et al., 1997; Abate et al., 1998) . The overall pattern of NF-jBimmunoreactivity in the brain obtained after iv LPS injection was very much reminiscent of that reported after systemic administration of the pro-inflammatory cytokine interleukin-1ß in mice (Nadjar et al., 2003) . In particular, the vasculature between the forebrain hemispheres where the azygos pericallosal artery runs and that of the Fig. 2 . Flow estimation in the mouse internal carotid arteries, ACA, anterior amygdaloid artery and azygos pericallosal artery with 3D TOF-MRA. The top part illustrates the levels at which ROIs were placed to measure the mean intensity of voxels in these arteries (A). Plates from mouse brain atlas (Paxinos and Franklin, 2001 ) indicate brain levels corresponding to the levels at which vessels were analyzed (A). The relative intensity of voxels in the internal carotid arteries (B), ACA (C), anterior amygdaloid artery (D) and azygos pericallosal artery (E) at different time points after iv LPS or saline injection are shown in graphs. ACA: anterior cerebral artery, Amy: amygdaloid artery, Azy: azygos pericallosal artery, IC: internal carotid (upstream of and as part of the circle of Willis). * p < 0.05, ** p < 0.01. Group sizes Sal: n = 9-10; LPS: n = 9-10. ventromedial forebrain meningeal surface containing the preoptic and lateral hypothalamic arteries displayed NF-jB-immunoreactivity after iv LPS injection ( Fig. 3 left panels). The choroid plexus showed an important concentration of round nuclear-like staining indicating nuclear translocation of NF-jB after iv LPS administration that was absent when the NF-jB antiserum was omitted (data not shown). Even though the round nuclear labeling was not observed in the absence of the NF-jB antiserum, some cytoplasmatic staining was found. This indicates that, in spite of the reported low cross reactivity with immunoglobulins of other species, the secondary antiserum did recognize some endogenous mouse immunoglobulins in the choroid plexus and meninges giving rise to some cytoplasmatic background staining. However, as only round nuclear-like labeling was taken into account as proxy for nuclear translocation, the cytoplasmatic background staining did generally not hinder analysis.
Since blood flow was found to be lower in the lateral parts of the circle of Willis formed by the internal carotids and in the ACA as well as in some downstream arteries, analyses were focused on these vascular territories. In particular, the azygos pericallosal artery and the preoptic and lateral hypothalamic arteries, which receive their input from the ACA, as well as for the latter from the MCA and internal carotids (Ambach et al., 1978; Dorr et al., 2007) , were studied. No or very light nuclear NF-jB-immunoreactivity was seen in vessels of saline-treated mice (Fig. 4A, E and I) . Iv LPS treatment resulted in nuclear NF-jB-immunoreactivity in meningeal cells and presumable veins (Fig. 4C, G) as these did not display autofluorescence under UV stimulation (Fig. 4D, H) . Although several preoptic and lateral hypothalamic arteries, identified by their autofluorescent walls (Fig. 3K , L) also showed some nuclear NK-jBimmunoreactivity after iv LPS administration (Fig. 4J) , this was of less intensity and much less widespread than in veins.
COX-2.
Constitutive expression of COX-2 was observed in neurons of the hippocampus, cerebral cortex and cerebellum, as previously reported (Elmquist et al., 1997; Konsman et al., 2004) . The vasculature between the forebrain hemispheres where the azygos pericallosal artery runs and that of the ventromedial forebrain meningeal surface containing the preoptic and lateral hypothalamic arteries showed COX-2immunoreactivity after iv LPS administration (Fig. 3 right  panels) . No or very light disk-shaped endothelial COX-2immunoreactivity was seen in the vessels between the two forebrain hemispheres of saline-treated mice (Fig. 5A) . In contrast, strong endothelial COX-2immunoreactivity with characteristic disk-shaped perinuclear labeling was observed in interhemsipheric vessels of mice injected iv with LPS ( Fig. 5C ). Neither constitutive neuronal nor LPS-induced vascular-associated labeling was observed when the COX-2 antiserum was omitted (data not shown). Since the vessels in which COX-2 was induced between the two hemispheres did not show UV-induced autofluorescence (Fig. 5D ), they were considered to be veins and venules. At the ventral surface of the forebrain, several vessels were found to strongly express COX-2 in the meninges of LPS-treated animals (Fig. 5E) . These vessels were identified as veins since they did not display autofluorescence under UV stimulation (Fig. 5F) . When patterns of COX-2-immunoreactivity in the ventral meninges were compared between mice injected with saline and those that were administered LPS, it turned out that many strongly COX-2-positive vessels were found in proximity to vessels lacking clear labeling in both experimental conditions (Fig. 5G, I) . In either condition, preoptic and lateral hypothalamic arteries identified by their autofluorescent walls (Fig. 5H, J) failed to show COX-2 immunoreactivity.
Nitrotyrosine. During inflammation, the production of important quantities of NO often occurs in parallel with that of reactive oxygen species and gives rise to the formation peroxynitrite, which, in turn, rapidly reacts with tyrosine residues to yield nitrotyrosine (Berg et al., 2011) . In the large vessels of the meninges, no clear differences in nitrotyrosine immunoreactivity were found between animals that received iv LPS 2.5 h earlier and those that were given its saline vehicle (Fig. 6A, B ). This lack of difference between groups was not due to a technical failure since we were able to detect occasional nitrotyrosine-immunoreactive vessels and perivascular cells (Fig. 6C, D) . Furthermore, neurons in the cerebellum of a mouse euthanized immediately after intraperitoneal injection of LPS were stained with our protocol (data not shown). This finding is in accordance with previous observations in naı¨ve mice (Mehl et al., 1999; Rodrigo et al., 2001) . Moreover, these cerebellar neurons showed increased nitrotyrosine-immunoreactivity in a mouse that was allowed to survive 6 h after intraperitoneal injection of LPS (10 lg corresponding to 300 lg/kg) (data not shown). Finally, positive signals were obtained throughout sections when they were artificially nitrosylated by incubating them in 1 mM sodium nitrite-and 1 mM H 2 O 2containing 0.1 M sodium acetate buffer (pH 5.0) for 20 min prior to the immunohistochemistry protocol (data not shown).
DISCUSSION
Time-resolved TOF MRA revealed no differences in blood flow in the internal carotids upstream of the circle of Willis, but indicated lower flow in its lateral parts as well as in the middle and anterior cerebral arteries after intravenous LPS injection as compared to saline administration. Intravenous LPS increased cerebral expression of COX-2 and prostaglandin E synthase mRNAs, but this de novo expression occurred in veins rather than in arteries.
The increase in blood flow in the circle of Willis and brain irrigating arteries over time after iv saline administration in control mice as shown by MRA in the present work corroborates results of previous studies measuring cerebral blood flow with arterial spin labeling and laser speckle flowmetry in intact rodents under isoflurane anesthesia (Sicard et al., 2003; Duong, 2007; Shin et al., 2007) . This isoflurane-induced rise in cerebral blood flow is partly mediated by increased NO production in the brain (McPherson et al., 1994; Kehl et al., 2002; Sjakste et al., 2005) . However, one needs to bear in mind that other inhaled anesthetics, at the same level of anesthesia, increase cerebral blood flow even more (Holmstrom and Akeson, 2005) . Hence, given the necessity for a stable level of anesthesia for the present exper-iments, an informed choice in favor of isoflurane was made in the present work.
The MRA findings obtained after iv LPS injection in mice are in accordance with clinical observations and expand experimental data. Indeed, clinical studies have observed anatomical signs of vasospasms in proximate branches of the ACA and MCA using MRA during sepsis-associated encephalopathy (Bartynski et al., 2006; Polito et al., 2013) . Moreover, flow speed in the territory of the MCA, as measured with transcranial Doppler, is reduced after iv LPS administration in healthy volunteers (Brassard et al., 2012) . However, no animal study so far has studied blood flow in the ACA and MCA and their proximate branches in experimental sepsis models. We were able to show, using 3D MRA, that iv LPS reduced flow in the ACA and one of its branches, the azygos pericallosal artery. Our findings expand experimental observations of increased resting blood flow velocity in the sensory cortex and vasodilation of subpial thirdorder arterioles and venules after iv administration of comparable doses of LPS in mice (Rosengarten et al., 2007 (Rosengarten et al., , 2008 Ruiz-Valdepenas et al., 2011) . This vasodilatation in arterioles downstream of the ACA and MCA may represent a physiological response to the reduced flow in these arteries after iv LPS administration. However, the finding that iv LPS decreases sensory stimulation-evoked blood flow responses in the cortex prior to, and, later on, in spite of, increased resting flow velocity indicates dysfunctional neurovascular coupling (Rosengarten et al., 2007) and may be explained by lower flow in upstream cerebral arteries as observed in the present work.
The time-resolved 3D MRA results obtained here also expand clinical observations in that they allow for quantitative measurements in high-flow systems and may therefore reveal hypo-or dysfunction well before anatomical signs of vasospasms would be visible on routinely used clinical MRA. Thus, our findings indicate that blood flow in the first segments of the mouse ACA and MCA is lower after iv LPS injection as compared to administration of its vehicle. Importantly, with timeresolved 3D MRA we were also able to show that flow in the carotid arteries downstream of the brain was not different between iv LPS and saline treatment. It was only when the internal carotids become part of the circle of Willis that flow turned out to be lower in iv LPSinjected mice than in control animals. These are important observations as they indicate that reduced flow in the first segments of the ACA and MCA during sepsis is not necessarily the consequence of systemic hypotension during bacteremia, but rather due to altered vasoregulation within the circle of Willis and in more downstream brain-irrigating arteries.
To identify potential mechanisms underlying decreased blood flow in the ACA and azygos pericallosal artery, we assessed the cerebral production of prostaglandins, NO and ET-1 as vasoactive mediators. ET-1 can be produced by cerebrovascular endothelial cells and is one of the most potent vasoconstrictors of cerebral arteries (Salom et al., 1995) . Although peripheral administration of LPS in rodent has been reported to increase prepro-ET-1 mRNA in the frontal cortex (Shimojo et al., 2006) , no differences in whole-brain preproET-1 mRNA expression were observed between iv LPS-and saline-treated mice in the present work. This apparent discrepancy can be explained by the fact that contrary to the previously published study, cells present in the circulatory system of the brain were rinsed with PBS in the present work. Indeed, murine mononuclear leukocytes produce prepro ET-1 mRNA in response to LPS (Wahl et al., 2005) and human circulating monocytes of septic patients contain significantly more ET-1 mRNA than those of healthy controls (Ebihara et al., 1998) . Since the ACA and MCA as well as meningeal and pial arteries express the endothelin A receptor (De Oliveira et al., 1995; Pierre and Davenport, 1995; Hansen-Schwartz et al., 2002) , this raises the possibility that ET-1 produced by circulating monocytes may exert vasoconstrictive effects on cerebral arteries during systemic inflammation. This hypothesis may be tested by repeating the experiments described here in wild-type mice that have received bone marrow depletion followed by transplantation with ET-1-deficient cells.
During systemic inflammation, the production of large quantities of NO by iNOS often occurs in parallel with that of reactive oxygen species and gives rise to the formation peroxynitrite (Berg et al., 2011) . This highly reactive molecule can nitrosylate proteins and stimulate contraction of smooth muscle cells of cerebral arteries (Elliott et al., 1998) . However, we found neither increased cerebral iNOS mRNA expression nor evidence of nitrosylation of tyrosine residues in brain arteries 2.5 h after iv LPS injection. The absence of increased iNOS mRNA expression during the first hours after iv LPS administration may be explained by its long induction time. In fact, only direct injection of LPS into the brain seems to result in a slight elevation of iNOS mRNA 2 h later (Okamoto et al., 1998) . Instead, it takes 6 h to observe a robust increase in iNOS mRNA regardless of whether LPS was administered intracerebrally or systemically (Wong et al., 1996; Okamoto et al., 1998) .
Although COX-2 within the context of inflammation is best known as the form of COX that is inducible by inflammatory mediators, it is important to point out that COX-2 is constitutively present in neurons and involved in the physiological coupling of neuronal activity and local changes in cerebral blood flow (Stefanovic et al., 2006) . Our RT-PCR analyses showed that iv LPS increased cerebral COX-2 mRNA expression to a similar extent as previously reported under comparable experimental conditions (Ruiz-Valdepenas et al., 2011) . In addition to its proper biological effects, COX-2-derived prostaglandin H 2 also constitutes an intermediate for the production of other vasoactive prostaglandins. Interestingly, we found that mPGES mRNA expression increased to a lesser extent than COX-2 mRNA after iv LPS. This differentially increased expression of COX-2 and mPGES after iv LPS suggests that not all prostaglandin H 2 produced will be immediately transformed into prostaglandin E 2 and that both mediators may potentially exert vasoactive effects.
To determine if de novo synthesis of prostaglandinsynthesizing enzymes occurred in brain-irrigating arteries, immunohistochemical detection of the transcription factor NF-jB, essential for COX-2 transcription (D'Acquisto et al., 1997; Abate et al., 1998) , as well as of COX-2 was employed. We observed that iv LPS treatment resulted in nuclear NF-jBimmunoreactivity mostly in veins and to a much less important extent in ACA-derived azygos pericallosal artery and preoptic and lateral hypothalamic arteries in the meninges. We have previously shown that LPSinduced COX-2 expression does not occur in alkaline phosphatase-positive arterioles of the brain parenchyma (Konsman et al., 2004) . However, this marker does not label meningeal arteries. Since rodent cerebral arteries rapidly respond to LPS in vitro by increasing COX-2 expression (Hernanz et al., 2004) , we set out to determine if meningeal arteries express COX-2 after iv LPS administration. In the present work, COX-2-immunoreactivity was observed in medium-sized and large vessels, often adjacent to arteries, but both in iv saline-and LPS-treated animals, even though it tended to be stronger in the latter. The presence of COX-2-immunoreactivity in cerebral vessels, presumably veins, of saline-injected rodents is in contrast to our previous findings obtained in animals that had not undergone isoflurane anesthesia (Konsman et al., 2004) , but may represent a biological response to isoflurane-induced reduction of cerebral prostaglandin E 2 contents (Sato et al., 1995) .
The absence of iv LPS-induced COX-2 expression in ACA-derived arteries observed here expands previous incidental mention of the lack of COX-2 expression in arteries identified by Giemsa stain after iv LPS administration (Elmquist et al., 1997) . mPGES is found in COX-2-positive vessels in the meninges and the brain parenchyma after peripheral LPS administration, but also seems to be absent from ''artery-like" vessels, based on morphological criteria (Yamagata et al., 2001; Eskilsson et al., 2014) . So even though prostaglandin H 2 , induces vasoconstriction in cerebral arteries (Toda et al., 1988; Davidge, 2001) and prostaglandin E 2 promotes vasoconstriction in cerebral arteries and cortical arterioles (Jadhav et al., 2004; Dabertrand et al., 2013) , their respective synthesizing enzymes are not induced in these vessels, but rather in adjacent veins, during systemic inflammation. Interestingly, systemic LPS administration also increases blood-borne prostaglandin E 2 (Tavares et al., 2006) and prostaglandin E receptors in large cerebral arteries and brain arterioles mediate vasoconstriction (Jadhav et al., 2004; Dabertrand et al., 2013) . It is therefore possible that circulating, rather than locally produced, prostaglandin E 2 mediates vasoconstrictive effects on cerebral arteries during systemic inflammation.
A rise in neuronal activity increases local as well as more upstream pial arterial blood flow (Iadecola, 2004) . As the preoptic region and the supraoptic and paraventricular nuclei of the hypothalamus receive their blood supply largely from the ACA and internal carotids (Ambach and Palkovits, 1974a,b; Ambach et al., 1978) , important changes in neuronal activity in these hypothalamic structures may have contributed to the differences in cerebral blood flow in these vessels between systemic saline and LPS administration. In the present work the number of cells expressing the activation marker c-Fos was not different between treatments in these structures, except for the paraventricular nucleus of the hypothalamus (PVH) where LPS was found to reduce expression of this cellular activation marker. These findings are at variance with previous reports, including our own, showing increased c-Fos expression in these rodent brain structures after systemic LPS administration in awake animals (Konsman et al., 1999) . Although the fact that LPS was injected in anesthesized animals in the present work may account for the absence of increased c-Fos expression in the ventromedian preoptic and supraoptic hypothalamus, this cannot explain reduced cellular activation in the PVH. With respect to the latter finding it is important to consider that, unlike in awake animals, c-Fos expression in this structure was already abundant in animals that received saline under isoflurane anesthesia. Although, exposure to anesthesia maintaining concentrations of isoflurane (0.6-1.5%) alone is not sufficient to induce c-Fos expression in the PVH (Sawamura et al., 2004) , both exposure to magnetic fields and radiofrequencies can increase c-Fos expression in the PVH (Ji et al., 1998; Jorge-Mora et al., 2011) . Since MRI involves both exposure to a magnetic field and to various radio waves, the high baseline c-Fos expression observed in the PVH may be related to our methodological choices. The fact that LPS then lowers PVH c-Fos expression in this context may not necessarily be relevant to the pathophysiology of sepsis and its complications. In addition, it is also important to keep in mind that the PVH contains only 21.500 neurons and represents 0.36 mm 3 (Kiss et al., 1991) and thus constitutes less than 5% of the rodent hypothalamus, which comprises about 10 mm 3 (Bouilleret et al., 2009) . It seems therefore unlikely that the lower arterial cerebral blood flow in the ACA and internal carotids of LPS-treated mice compared to their salineinjected controls was related to changes in neuronal activity in the hypothalamus.
CONCLUSION
Our work indicates that during LPS-induced systemic inflammation no changes occur in the filling of the circle of the Willis from the periphery, but that circulating LPS alters outflow from the circle of Willis to the middle and anterior cerebral arteries. These modifications in arterial flow were not related to increased cerebral synthesis of prostaglandins, but may be the consequence of the action of circulating prostaglandins and other vasoactive mediators on brain-irrigating arteries during systemic inflammation.
